<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01385865</url>
  </required_header>
  <id_info>
    <org_study_id>MLE_Biofood_2</org_study_id>
    <nct_id>NCT01385865</nct_id>
  </id_info>
  <brief_title>Effect of Mulberry Leaf Extract on Blood Glucose</brief_title>
  <official_title>Effect of Mulberry Leaf Extract on Blood Glucose in Subjects With Impaired Fasting Glucose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ewha Womans University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CHA University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Knowledge Economy, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ewha Womans University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose
      in subjects with impaired fasting glucose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose
      in subjects with impaired fasting glucose. After 2 weeks run-in period for wash-out, subjects
      will randomly assigned to two groups, i.e. control group (placebo) or mulberry leaf extract
      group. They will intake placebo or mulberry leaf extract for 4 weeks. Biomarkers will be
      analyzed in blood samples in 0 and 4 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood glucose change with meal tolerance test</measure>
    <time_frame>0wk</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood glucose change with meal tolerance test</measure>
    <time_frame>4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin and C-peptide changes with meal tolerance test</measure>
    <time_frame>0, 4 wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting blood glucose</measure>
    <time_frame>0, 4 wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-peptide</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated albumin</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High sensitivity C-reactive protein</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidized low-density lipoprotein</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile (triglyceride, total cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, high-density lipoprotein cholesterol)</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Prediabetic State</condition>
  <arm_group>
    <arm_group_label>Mulberry leaf extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mulberry leaf extract</intervention_name>
    <description>18 tablets/day (6 tablets/serving x 3servings/day, mulberry leaf extract 336mg/1 tablet (800mg), 1-Deoxynojirimycin 4.3mg/1 g mulberry leaf extract), Duration: 4 weeks</description>
    <arm_group_label>Mulberry leaf extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>18 tablets/day (6 tablets/serving x 3servings/day, lactose 511mg/1 tablet (650mg)), Duration: 4 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: over 20 years

          -  Fasting glucose: 100mg/dl ≤ ~ ≤ 125mg/dl

          -  HbA1c: &lt; 6.5%

        Exclusion Criteria:

          -  Subject who has taken medicines, Chinese medicines and Health/Functional Foods which
             can affect glucose metabolism in 30 days prior to screening visit

          -  Subject who has taken part in other clinical trials in 30 days prior to screening
             visit

          -  Subject who is pregnant or breast feeding

          -  Subject who lost body weight over 4 kg in 30 days prior to screening visit

          -  Alcoholic

          -  Heavy smoker (≥ 20 cigarettes/day)

          -  Subject who has heart failure, coronary artery disease, uncontrolled hypertension (≥
             140/90mmHg), diabetes (fasting blood glucose ≥ 126mg/dL), renal dysfunction, liver
             failure, hyperthyroidism, hypothyroidism, cancer or mental disease

          -  Subject who has an allergy to the ingredients of study product
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oran Kwon, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ewha Womans University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sung Won Kwon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHA University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seok Won Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHA University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moon Jong Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHA University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bundang CHA Medical Center</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-Do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2011</study_first_submitted>
  <study_first_submitted_qc>June 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2011</study_first_posted>
  <last_update_submitted>October 27, 2011</last_update_submitted>
  <last_update_submitted_qc>October 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ewha Womans University</investigator_affiliation>
    <investigator_full_name>Oran Kwon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

